Status:
COMPLETED
Efficacy of Gelatin Tannate in Treatment Acute Gastroenteritis in Children.
Lead Sponsor:
Medical University of Warsaw
Conditions:
Acute Gastroenteritis
Eligibility:
All Genders
Up to 5 years
Phase:
PHASE1
Brief Summary
Gelatin tannate possesses astringent, antibacterial, and anti-inflammatory properties. It is increasingly being marketed as an antidiarrheal drug. A randomized, double blind, placebo-control trial was...
Eligibility Criteria
Inclusion
- children \< 5 years old
- diarrhea (defined as the passage of 3 or more loose or watery stools per day) for \> 1 day but \< 5 days
- inform consent sign
Exclusion
- regularly used antibiotics, probiotics, gelatin tannate, diosmectite, racecadotril within 7 days before admission
- underlying gastrointestinal tract disorder presenting with diarrhea
- breastfeeding \>50%
- malnutrition (weight/high \<3pc)
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 10 2017
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT02280759
Start Date
November 1 2014
End Date
June 10 2017
Last Update
July 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Paediatrics, The Medical University of Warsaw, Poland
Warsaw, Poland, 01-183